share_log

BioVie | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(7.6%),3i Management LLC(7.6%), etc.

BioVie | SC 13G: Statement of acquisition of beneficial ownership by individuals-3i, LP(7.6%),3i Management LLC(7.6%), etc.

BioVie | SC 13G:超過5%持股股東披露文件-3i, LP(7.6%),3i Management LLC(7.6%)等
美股SEC公告 ·  2024/10/26 04:03

牛牛AI助理已提取核心訊息

On October 22, 2024, a Schedule 13G filing was made with the U.S. Securities and Exchange Commission by 3i, LP, 3i Management LLC, and Maier Joshua Tarlow, collectively reporting a shared voting and dispositive power over 1,260,000 shares of BioVie Inc.'s Class A common stock. This stake represents 7.6% of the company's issued shares, based on the 16,612,374 shares outstanding as reported in BioVie's prospectus supplement dated October 23, 2024. The filing indicates that the shares are beneficially owned by 3i, LP and that 3i Management LLC, as the general partner and manager of 3i, LP, along with Maier Joshua Tarlow, as the manager of 3i Management LLC, have shared power to vote and dispose of the shares. The reporting persons have entered into a Joint Filing Agreement, indicating that they will file jointly for any subsequent amendments. The filing emphasizes that the acquisition of the shares is not for the purpose of changing or influencing the control of BioVie Inc. and is not connected with any transaction with such purpose or effect.
On October 22, 2024, a Schedule 13G filing was made with the U.S. Securities and Exchange Commission by 3i, LP, 3i Management LLC, and Maier Joshua Tarlow, collectively reporting a shared voting and dispositive power over 1,260,000 shares of BioVie Inc.'s Class A common stock. This stake represents 7.6% of the company's issued shares, based on the 16,612,374 shares outstanding as reported in BioVie's prospectus supplement dated October 23, 2024. The filing indicates that the shares are beneficially owned by 3i, LP and that 3i Management LLC, as the general partner and manager of 3i, LP, along with Maier Joshua Tarlow, as the manager of 3i Management LLC, have shared power to vote and dispose of the shares. The reporting persons have entered into a Joint Filing Agreement, indicating that they will file jointly for any subsequent amendments. The filing emphasizes that the acquisition of the shares is not for the purpose of changing or influencing the control of BioVie Inc. and is not connected with any transaction with such purpose or effect.
2024年10月22日,由3i, LP,3i管理有限責任公司和Maier Joshua Tarlow共同提交給美國證券交易委員會的第13G表格,共同報告對BioVie Inc.的A類普通股1,260,000股的共同投票權和處置權。根據BioVie於2024年10月23日的招股說明書中報告的16,612,374股股份,這一股權佔公司已發行股份的7.6%。報告表明,這些股份由3i, LP受益所有,並且3i管理有限責任公司作爲3i, LP的普通合夥人和經理,以及Maier Joshua Tarlow作爲3i管理有限責任公司的經理,共同具有投票和處置這些股份的權力。報告人已簽署了聯合申報協議,表明他們將共同提交任何後續修訂。此次提交強調,收購這些股份並非出於改變或影響BioVie Inc.控制權的目的,並且與任何具有此類目的或影響的交易無關。
2024年10月22日,由3i, LP,3i管理有限責任公司和Maier Joshua Tarlow共同提交給美國證券交易委員會的第13G表格,共同報告對BioVie Inc.的A類普通股1,260,000股的共同投票權和處置權。根據BioVie於2024年10月23日的招股說明書中報告的16,612,374股股份,這一股權佔公司已發行股份的7.6%。報告表明,這些股份由3i, LP受益所有,並且3i管理有限責任公司作爲3i, LP的普通合夥人和經理,以及Maier Joshua Tarlow作爲3i管理有限責任公司的經理,共同具有投票和處置這些股份的權力。報告人已簽署了聯合申報協議,表明他們將共同提交任何後續修訂。此次提交強調,收購這些股份並非出於改變或影響BioVie Inc.控制權的目的,並且與任何具有此類目的或影響的交易無關。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。